Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Autoimmune Disorders

Free Subscription Articles published in Arch Neurol Retrieve available abstracts of 78 articles: HTML format Text format

Single Articles

January 2012
1. MUPPIDI S , Scribner M, Gibbons CH, Adams-Huet B, et al
   A Unique Manifestation of Pupillary Fatigue in Autoimmune Autonomic Ganglionopathy.
   Arch Neurol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. POOL V , Gordon DM, Decker M
   Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow Fever vaccination.
   Arch Neurol. 2012;69:144.
   PubMed     Text format     Related articles   
   
   
   
   
3. MARCUS JF , Shalev SM, Harris CA, Goodin DS, et al
   Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution.
   Arch Neurol. 2012;69:129-32.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. CARAMANOS Z , Francis SJ, Narayanan S, Lapierre Y, et al
   Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis.
   Arch Neurol. 2012;69:89-95.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. CHERIYAN J , Kim S, Wolansky LJ, Cook SD, et al
   Impact of inflammation on brain volume in multiple sclerosis.
   Arch Neurol. 2012;69:82-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. GORMAN MP , Tillema JM, Ciliax AM, Guttmann CR, et al
   Daclizumab use in patients with pediatric multiple sclerosis.
   Arch Neurol. 2012;69:78-81.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
7. GIBBONS CH , Centi J, Vernino S, Freeman R, et al
   Autoimmune Autonomic Ganglionopathy With Reversible Cognitive Impairment.
   Arch Neurol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. RICHMAN DP
   Antibodies to Low Density Lipoprotein Receptor-Related Protein 4 in Seronegative Myasthenia Gravis.
   Arch Neurol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
9. ZHANG B , Tzartos JS, Belimezi M, Ragheb S, et al
   Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis.
   Arch Neurol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. ORTIZ GA , Lagari-Libhaber V, Prieto-Sanchez LM, Rabinstein AA, et al
    Propylthiouracil-induced lupus, antiphospholipid syndrome, and stroke in a patient with graves hyperthyroidism.
    Arch Neurol. 2011;68:1587-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. FILIPPI M , Rocca MA, De Stefano N, Enzinger C, et al
    Magnetic resonance techniques in multiple sclerosis: the present and the future.
    Arch Neurol. 2011;68:1514-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. WILLIAMS MA , Venkatesan A
    No endovascular innovation without evaluation in chronic cerebrospinal venous insufficiency: a call for the IDEAL model.
    Arch Neurol. 2011;68:1510-2.
    PubMed     Text format     Related articles   
    
    
    
    November 2011
13. TUR C , Montalban X, Tintore M, Nos C, et al
    Interferon Beta-1b for the Treatment of Primary Progressive Multiple Sclerosis: Five-Year Clinical Trial Follow-up.
    Arch Neurol. 2011;68:1421-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. FINELLI PF , Uphoff DF
    Ring sign on diffusion-weighted imaging.
    Arch Neurol. 2011;68:1474-5.
    PubMed     Text format     Related articles   
    
    
    
    
15. CHAN KH , Tse CT, Chung CP, Lee RL, et al
    Brain involvement in neuromyelitis optica spectrum disorders.
    Arch Neurol. 2011;68:1432-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. SAURE C , Warnke C, Zohren F, Schroeder T, et al
    Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors.
    Arch Neurol. 2011;68:1428-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. KIM SH , Kim W, Li XF, Jung IJ, et al
    Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.
    Arch Neurol. 2011;68:1412-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
18. KINKEL RP , Dontchev M, Kollman C, Skaramagas TT, et al
    Association Between Immediate Initiation of Intramuscular Interferon Beta-1a at the Time of a Clinically Isolated Syndrome and Long-term Outcomes: A 10-Year Follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Ne
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. SHOAMANESH A , Chapman K, Traboulsee A
    Postvaccination Miller Fisher syndrome.
    Arch Neurol. 2011;68:1327-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
20. ZHANG HL , Li HF
    The TH1/TH2 paradigm in guillain-barre syndrome.
    Arch Neurol. 2011;68:1209.
    PubMed     Text format     Related articles   
    
    
    
    
21. QIAN P , Cross AH, Naismith RT
    Lack of response to monoclonal antibody therapy in neuromyelitis optica.
    Arch Neurol. 2011;68:1207-9.
    PubMed     Text format     Related articles   
    
    
    
    
22. GHAVANINI AA , Munoz DG
    Primary cerebral angiitis associated with amyloid angiopathy.
    Arch Neurol. 2011;68:1202-3.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
23. MARDER E , Gupta P, Greenberg BM, Frohman EM, et al
    No Cerebral or Cervical Venous Insufficiency in US Veterans With Multiple Sclerosis.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. VAKNIN-DEMBINSKY A , Abramsky O, Petrou P, Ben-Hur T, et al
    Myasthenia Gravis-Associated Neuromyelitis Optica-Like Disease: An Immunological Link Between the Central Nervous System and Muscle?
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SMITH JH , Dhamija R, Moseley BD, Sandroni P, et al
    N -methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-Myoclonus: Treatment Response to Plasmapheresis.
    Arch Neurol. 2011;68:1069-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. KORFF CM , Parvex P, Cimasoni L, Wilhelm-Bals A, et al
    Encephalitis associated with glutamic Acid decarboxylase autoantibodies in a child: a treatable condition?
    Arch Neurol. 2011;68:1065-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. KITLEY JL , Leite MI, Matthews LA, Palace J, et al
    Use of mitoxantrone in neuromyelitis optica.
    Arch Neurol. 2011;68:1086.
    PubMed     Text format     Related articles   
    
    
    
    
28. AMBROSE CS , Loop B, Miday R
    A case report of transverse myelitis following influenza vaccination.
    Arch Neurol. 2011;68:1085.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
29. BAGERT BA , Marder E, Stuve O
    Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. KARACOSTAS D , Hadjigeorgiou G, Ioannidis P, Milonas I, et al
    How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?
    Arch Neurol. 2011;68:955.
    PubMed     Text format     Related articles   
    
    
    
    
31. COLLONGUES N , Cabre P, Marignier R, Zephir H, et al
    A benign form of neuromyelitis optica: does it exist?
    Arch Neurol. 2011;68:918-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. UZAWA A , Mori M, Masuda S, Kuwabara S, et al
    Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica.
    Arch Neurol. 2011;68:913-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. LIN CS , Krishnan AV, Park SB, Kiernan MC, et al
    Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
    Arch Neurol. 2011;68:862-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. HUGHES RA , Mills K
    Improvement of axonal function in patients with chronic inflammatory demyelinating polyneuropathy after intravenous immunoglobulin therapy.
    Arch Neurol. 2011;68:844-6.
    PubMed     Text format     Related articles   
    
    
    
    
35. MATIELLO M , Pittock SJ, Porrata L, Weinshenker BG, et al
    Failure of autologous hematopoietic stem cell transplantation to prevent relapse of neuromyelitis optica.
    Arch Neurol. 2011;68:953-5.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
36. MCKEON A , Tracy JA, Pittock SJ, Parisi JE, et al
    Purkinje Cell Cytoplasmic Autoantibody Type 1 Accompaniments: The Cerebellum and Beyond.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. FAREZ MF , Correale J
    Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. CORNELIUS JR , Pittock SJ, McKeon A, Lennon VA, et al
    Sleep manifestations of voltage-gated potassium channel complex autoimmunity.
    Arch Neurol. 2011;68:733-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
39. MARELLI C , van de Leemput J, Johnson JO, Tison F, et al
    SCA15 Due to Large ITPR1 Deletions in a Cohort of 333 White Families With Dominant Ataxia.
    Arch Neurol. 2011;68:637-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
40. TAJZOY E , Mukherjee S, Vernino S
    Autonomic Ganglia neuronal density and synaptic structure in chronic experimental autoimmune autonomic ganglionopathy.
    Arch Neurol. 2011;68:540-1.
    PubMed     Text format     Related articles   
    
    
    
    
41. BUNYAN RF , Popescu BF, Carter JL, Caselli RJ, et al
    Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination.
    Arch Neurol. 2011;68:525-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. MANGANELLI F , Dubbioso R, Nolano M, Iodice R, et al
    Autoimmune autonomic ganglionopathy: a possible postganglionic neuropathy.
    Arch Neurol. 2011;68:504-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. BUCK D , Cepok S, Hoffmann S, Grummel V, et al
    Influence of the HLA-DRB1 Genotype on Antibody Development to Interferon Beta in Multiple Sclerosis.
    Arch Neurol. 2011;68:480-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. RAMAGOPALAN SV , Meier UC, Conacher M, Ebers GC, et al
    Role of the HLA System in the Association Between Multiple Sclerosis and Infectious Mononucleosis.
    Arch Neurol. 2011;68:469-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. CREE BA , Stuart WH, Tornatore CS, Jeffery DR, et al
    Efficacy of Natalizumab Therapy in Patients of African Descent With Relapsing Multiple Sclerosis: Analysis of AFFIRM and SENTINEL Data.
    Arch Neurol. 2011;68:464-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. NYATI KK , Prasad KN, Rizwan A, Verma A, et al
    TH1 and TH2 Response to Campylobacter jejuni Antigen in Guillain-Barre Syndrome.
    Arch Neurol. 2011;68:445-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. LAMBRACHT-WASHINGTON D , Wolfe GI
    Cytokines in guillain-barre syndrome: a lesson in time.
    Arch Neurol. 2011;68:427-8.
    PubMed     Text format     Related articles   
    
    
    
    
48. COYLE PK
    Pediatric multiple sclerosis: just like their elders?
    Arch Neurol. 2011;68:419-21.
    PubMed     Text format     Related articles   
    
    
    
    
49. ALMEKHLAFI MA , Clark AW, Lucchinetti CF, Zhang Y, et al
    Neuromyelitis optica with extensive active brain involvement: an autopsy study.
    Arch Neurol. 2011;68:508-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. KIM SH , Kim W, Park MS, Sohn EH, et al
    Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica.
    Arch Neurol. 2011;68:473-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
51. GILLI F , Navone ND, Perga S, Marnetto F, et al
    Loss of Braking Signals During Inflammation: A Factor Affecting the Development and Disease Course of Multiple Sclerosis.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
52. STUVE O , Wang J, Chan A, Hemmer B, et al
    No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
    Arch Neurol. 2011;68:264-5.
    PubMed     Text format     Related articles   
    
    
    
    
53. BURSAW A , Duginski T
    Anterior opercular syndrome caused by acute, simultaneous, isolated bilateral infarcts.
    Arch Neurol. 2011;68:254-5.
    PubMed     Text format     Related articles   
    
    
    
    
54. JONES DT , Mateen FJ, Lucchinetti CF, Jack CR Jr, et al
    Default mode network disruption secondary to a lesion in the anterior thalamus.
    Arch Neurol. 2011;68:242-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
55. YEH EA , Waubant E, Krupp LB, Ness J, et al
    Multiple Sclerosis Therapies in Pediatric Patients With Refractory Multiple Sclerosis.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. JOHNSON TA , Lapierre Y, Bar-Or A, Antel JP, et al
    Distinct Properties of Circulating CD8+ T Cells in FTY720-Treated Patients With Multiple Sclerosis.
    Arch Neurol. 2010;67:1449-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
57. LANGER-GOULD A , Huang S, Van Den Eeden SK, Gupta R, et al
    Vitamin D, Pregnancy, Breastfeeding, and Postpartum Multiple Sclerosis Relapses.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. HOLLENBECK R , Black BK, Peltier AC, Biaggioni I, et al
    Long-term Treatment With Rituximab of Autoimmune Autonomic Ganglionopathy in a Patient With Lymphoma.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. IORIO R , Plantone D, Frisullo G, Nociti V, et al
    Focal hyperhidrosis in tumefactive multiple sclerosis.
    Arch Neurol. 2010;67:1407-8.
    PubMed     Text format     Related articles   
    
    
    
    
60. KLAWITER EC , Benzinger T, Roy A, Naismith RT, et al
    Spinal cord ring enhancement in multiple sclerosis.
    Arch Neurol. 2010;67:1395-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
61. MIRAVALLE A , Jensen R, Kinkel RP
    Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. KARUSSIS D , Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, et al
    Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
    Arch Neurol. 2010;67:1187-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. KALLURI SR , Illes Z, Srivastava R, Cree B, et al
    Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica.
    Arch Neurol. 2010;67:1201-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
64. ECHANIZ-LAGUNA A , Chassagne M, de Seze J, Mohr M, et al
    POLG1 Variations Presenting as Multiple Sclerosis.
    Arch Neurol. 2010;67:1140-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. PITTOCK SJ , Parisi JE, McKeon A, Roemer SF, et al
    Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-ri).
    Arch Neurol. 2010;67:1109-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. KLAWITER EC , Piccio L, Lyons JA, Mikesell R, et al
    Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.
    Arch Neurol. 2010;67:1102-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. KHOURY SJ , Healy BC, Kivisakk P, Viglietta V, et al
    A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis.
    Arch Neurol. 2010;67:1055-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. PACHECO MF , Jacobe H, Eagar TN, Stuve O, et al
    Reversible alopecia associated with glatiramer acetate.
    Arch Neurol. 2010;67:1154.
    PubMed     Text format     Related articles   
    
    
    
    
69. BICHUETTI DB , Lobato de Oliveira EM, Oliveira DM, Amorin de Souza N, et al
    Neuromyelitis optica treatment: analysis of 36 patients.
    Arch Neurol. 2010;67:1131-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. SOMINANDA A , Lundkvist M, Fogdell-Hahn A, Hemmer B, et al
    Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta.
    Arch Neurol. 2010;67:1095-101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. CABRERA SERRANO M , Rabinstein AA
    Causes and outcomes of acute neuromuscular respiratory failure.
    Arch Neurol. 2010;67:1089-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. DONOFRIO PD , Bril V, Dalakas MC, Deng C, et al
    Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy.
    Arch Neurol. 2010;67:1082-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
73. KHANIFAR AA , Parlitsis GJ, Gauthier SA, Kiss S, et al
    Evaluating retinal abnormalities in patients with multiple sclerosis.
    Arch Neurol. 2010;67:1035.
    PubMed     Text format     Related articles   
    
    
    
    
74. RAMAGOPALAN SV , Hanwell HE, Giovannoni G, Knappskog PM, et al
    Vitamin D-Dependent Rickets, HLA-DRB1, and the Risk of Multiple Sclerosis.
    Arch Neurol. 2010;67:1034-5.
    PubMed     Text format     Related articles   
    
    
    
    
75. AKKAD W , Salem B, Freeman JW, Huntington MK, et al
    Longitudinally extensive transverse myelitis following vaccination with nasal attenuated novel influenza A(H1N1) vaccine.
    Arch Neurol. 2010;67:1018-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. PALACE J , Leite MI, Nairne A, Vincent A, et al
    Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
    Arch Neurol. 2010;67:1016-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
77. WOLF C , Menge T, Stenner MP, Meyer zu Horste G, et al
    Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy.
    Arch Neurol. 2010;67:881-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. LATOV N , Deng C, Dalakas MC, Bril V, et al
    Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Arch Neurol. 2010;67:802-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: